Cargando…
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) global pandemic significantly impacted CF clinical research within the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN). A Research Electronic Data Capture (REDCap) survey was developed and sent to network sites to m...
Autores principales: | Pearson, Kelsie, Mayer-Hamblett, Nicole, Goss, Christopher H., Retsch-Bogart, George Z., VanDalfsen, Jill M., Burks, Patricia, Rosenbluth, Daniel, Clancy, John Paul, Hoffman, Amy, Nichols, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834129/ https://www.ncbi.nlm.nih.gov/pubmed/33349583 http://dx.doi.org/10.1016/j.jcf.2020.12.007 |
Ejemplares similares
-
Evaluating the Impact of Stopping Chronic Therapies after Modulator
Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study
Design
por: Mayer-Hamblett, Nicole, et al.
Publicado: (2021) -
A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis
por: Paynter, Alex, et al.
Publicado: (2022) -
Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial
por: Cunningham, Fiona, et al.
Publicado: (2022) -
Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
por: Crull, Mathew R., et al.
Publicado: (2016) -
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design
por: Jain, Raksha, et al.
Publicado: (2022)